De NBCA brengt ieder jaar een eigen jaarverslag uit. Lees het jaarverslag 2019 hier.

Ieder jaar publiceert DICA de resultaten van de registraties. Dit geeft een beeld van de kwaliteit van de zorg in Nederland. De resultaten over 2019 zijn, per registratie, te vinden in de online jaarrapportage. 

Publicaties met data uit de NBCA:

2020

• Association between initiation of adjuvant chemotherapy beyond 30 days after surgery and overall survival among patients with triple-negative breast cancer. Heeg E, Marang-van de Mheen PJ, Van Maaren MC, Schreuder K, Tollenaar RAEM, Siesling S, Bos MEMM, Vrancken Peeters MTFD. Int J Cancer. 2020 Jul 1;147(1):152-159.
• Breast-contour preserving procedures for early-stage breast cancer: a population-based study of the trends, variation in practice and predictive characteristics in Denmark and the Netherlands. Heeg E, Jensen MB, Mureau MAM, Ejlertsen B, Tollenaar RAEM, Christiansen PM, Vrancken Peeters MTFD. Breast Cancer Res Treat. 2020; 182(3): 709–718.

2019

• Nationwide Population-Based Study on the Impact of Postmastectomy Immediate Breast Reconstruction on the Timing of Adjuvant Chemotherapy. Erik Heeg, J.X.Harmeling, B. E. Becherer, P. J. Marang-van de Mheen, M.T.F.D.Vrancken Peeters and M.A.M.Mureau. Br J Surg. 2019 Nov;106(12):1640-1648.
• Immediate breast reconstruction in the Netherlands and the United States: a proof 524 of concept to internationally compare quality of care using cancer registry data. K Parisa, A van Bommel, B Becherer, C Rodney, M Mureau, A Pusci, S Siesling, R van 526 der Hulst, S Lin, H Rakhors. Plast Reconstr Surg. 2019 Oct;144(4):565e-574e.
• Breast contour preserving procedure as a multidisciplinary parameter of aesthetic outcome in breast cancer treatment. Annnelotte van Bommel, Pauline Spronk, Marc Mureau, Sabine Siesling, Carolien Smorenburg, Marie-Jeanne Vrancken Peeters, Thijs van Dalen. Ann Surgical Oncology 2019 jun 26(6):1704-1711. Epub 2019 Mar 4.
• Variation in the Use of Boost Irradiation in Breast-Conserving Therapy in the Netherlands: The Effect of a National Guideline and Cofounding Factors. Schreuder K, Maduro JH, Spronk PER, Bijker N, Poortmans PMP, van Dalen T, Struikmans H, Siesling S.Clin Oncol (R Coll Radiol). 2019 Apr;31(4):250-259.
• Hospital transfer after a breast cancer diagnosis: a population-based study in the Netherlands of the extent, predictive characteristics and its impact on time to treatment. E. Heeg, K. Schreuder, P.E.R. Spronk, J.C. Oosterwijk, P.J. Marang-van de Mheen, S. Siesling, M.T.F.D. Vrancken Peeters. Eur J Surg Oncol. 2019 Apr;45(4):560-566.
• Breast conserving therapy after neoadjuvant chemotherapy ; data from the Dutch Breast Cancer Audit. Pauline E.R. Spronk , José H. Volders, Petrousjka van den Tol , Carolien H. Smorenburg, Marie-Jeanne T.F.D. Vrancken Peeters. Eur J Surg Oncol. 2019 Feb;45(2):110-117.

2018

• Current decisions on neoadjuvant chemotherapy for early breast cancer: Experts' experiences in the Netherlands. Spronk PER, de Ligt KM, van Bommel ACM, Siesling S, Smorenburg CH, Vrancken Peeters MTFD; NABON Breast Cancer Audit. Patient Educ Couns. 2018 Dec;101(12):2111-2115. 
• Discrepancies Between Surgical Oncologists and Plastic Surgeons in Patient Information Provision and Personal Opinions Towards Immediate Breast Reconstruction. van Bommel ACM, Schreuder K, Veenstra RK, de Ligt KM, Vrancken Peeters MTFD, Maduro JH, Siesling S, Mureau MAM. Ann Plast Surg. 2018 Oct;81(4):383-388. 
• 11.    The administration of adjuvant chemo(-immuno) therapy in the post ACOSOG-Z0011 era; a population based study. Poodt IGM, Rots ML, Vugts G, van Dalen T, Kuijer A, Vriens BEPJ, Nieuwenhuijzen GAP, Schipper RJ. Eur J Surg Oncol. 2018 Aug;44(8):1151-1156. 
• The effect of being informed on receiving immediate breast reconstruction in breast cancer patients. de Ligt KM, van Bommel ACM, Schreuder K, Maduro JH, Vrancken Peeters MTFD, Mureau MAM, Siesling S; NABON Breast Cancer Audit Working Group. Eur J Surg Oncol. 2018 May;44(5):717-724. 
• Patients' experiences with decisions on timing of chemotherapy for breast cancer. de Ligt KM, Spronk PER, van Bommel ACM, Vrancken Peeters MTFD, Siesling S, Smorenburg CH; Nabon Breast Cancer Audit group. Breast. 2018 Feb;37:99-106. 
• Trends on Axillary Surgery in Nondistant Metastatic Breast Cancer Patients Treated Between 2011 and 2015: A Dutch Population-based Study in the ACOSOG-Z0011 and AMAROS Era. Poodt IGM, Spronk PER, Vugts G, van Dalen T, Peeters MTFDV, Rots ML, Kuijer A, Nieuwenhuijzen GAP, Schipper RJ. Ann Surg. 2018 Dec;268(6):1084-1090. 

2017

• Variation in use of neoadjuvant chemotherapy in patients with stage III breast cancer: Results of the Dutch national breast cancer audit. Spronk PER, van Bommel ACM, Siesling S, Wouters MWJM, Vrancken Peeters MTFD, Smorenburg CH. Breast. 2017 Dec;36:34-38.
• Breast magnetic resonance imaging use in patients undergoing neoadjuvant chemotherapy is associated with less mastectomies in large ductal cancers but not in lobular cancers. Vriens IJH, Keymeulen K, Lobbes MBI, van Bommel ACM, Nieuwenhuijzen GAP, Smidt ML, Boersma LJ, van Dalen T, Smorenburg CH, Struikmans H, Siesling S, Voogd AC, Tjan-Heijnen VCG; National Breast Cancer Organization of the Netherlands – Breast Cancer Audit Scientific Committee (NBCA). Eur J Cancer. 2017 Aug;81:74-80. 
• Hospital organizational factors affect the use of immediate breast reconstruction after mastectomy for breast cancer in the Netherlands. Schreuder K, van Bommel ACM, de Ligt KM, Maduro JH, Vrancken Peeters MTFD, Mureau MAM, Siesling S. Breast. 2017 Aug;34:96-102. 
• Large variation between hospitals in immediate breast reconstruction rates after mastectomy for breast cancer in the Netherlands. van Bommel AC, Mureau MA, Schreuder K, van Dalen T, Vrancken Peeters MT, Schrieks M, Maduro JH, Siesling S. J Plast Reconstr Aesthet Surg. 2017 Feb;70(2):215-221. 
• Clinical auditing as an instrument for quality improvement in breast cancer care in the Netherlands: The national NABON Breast Cancer Audit. van Bommel AC, Spronk PE, Vrancken Peeters MT, Jager A, Lobbes M, Maduro JH, Mureau MA, Schreuder K, Smorenburg CH, Verloop J, Westenend PJ, Wouters MW, Siesling S, Tjan-Heijnen VC, van Dalen T; NABON Breast Cancer Audit. J Surg Oncol. 2017 Mar;115(3):243-249.